These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 11275983
1. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Höppner W, Stavrou D, Fillbrandt R, Westphal M. Int J Cancer; 2001 Mar 15; 91(6):803-8. PubMed ID: 11275983 [Abstract] [Full Text] [Related]
2. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A. Am J Pathol; 1999 Aug 15; 155(2):627-32. PubMed ID: 10433955 [Abstract] [Full Text] [Related]
3. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, Cogen PH. Genes Chromosomes Cancer; 1996 Sep 15; 17(1):37-44. PubMed ID: 8889505 [Abstract] [Full Text] [Related]
4. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Kraus JA, de Millas W, Sörensen N, Herbold C, Schichor C, Tonn JC, Wiestler OD, von Deimling A, Pietsch T. Acta Neuropathol; 2001 Jul 15; 102(1):69-74. PubMed ID: 11547953 [Abstract] [Full Text] [Related]
6. Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Huang B, Starostik P, Schraut H, Krauss J, Sörensen N, Roggendorf W. Acta Neuropathol; 2003 Oct 15; 106(4):357-62. PubMed ID: 12898154 [Abstract] [Full Text] [Related]
7. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN. Cancer Res; 1994 Jan 01; 54(1):45-7. PubMed ID: 8261460 [Abstract] [Full Text] [Related]
8. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas. Rousseau-Merck M, Versteege I, Zattara-Cannoni H, Figarella D, Lena G, Aurias A, Vagner-Capodano AM. Cancer Genet Cytogenet; 2000 Sep 01; 121(2):223-7. PubMed ID: 11063814 [Abstract] [Full Text] [Related]
10. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN. Neurosurgery; 1996 Jul 01; 39(1):135-40. PubMed ID: 8805149 [Abstract] [Full Text] [Related]
11. A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor. Yokota T, Tachizawa T, Fukino K, Teramoto A, Kouno J, Matsumoto K, Emi M. J Hum Genet; 2003 Jul 01; 48(11):598-602. PubMed ID: 14566482 [Abstract] [Full Text] [Related]
12. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Ammerlaan AC, de Bustos C, Ararou A, Buckley PG, Mantripragada KK, Verstegen MJ, Hulsebos TJ, Dumanski JP. Genes Chromosomes Cancer; 2005 Aug 01; 43(4):329-38. PubMed ID: 15880457 [Abstract] [Full Text] [Related]
18. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Slavc I, MacCollin MM, Dunn M, Jones S, Sutton L, Gusella JF, Biegel JA. Int J Cancer; 1995 Aug 22; 64(4):243-7. PubMed ID: 7657387 [Abstract] [Full Text] [Related]